SAI
ABMD

Systematic Alpha Investments’s Abiomed Inc ABMD Stock Holding History

Systematic Alpha Investments’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-202
Closed -$67K – 494
2021
Q3 		$67K Buy
+202
New +$68.4K ﹤0.01% 298

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Systematic Alpha Investments's ABMD Position: Q4 2021 in Review

Systematic Alpha Investments sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 202 shares — an estimated $67K sold.

Systematic Alpha Investments first reported a position in ABMD in Q3 2021 and held it in 1 quarter. The position peaked at $67K in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Systematic Alpha Investments reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Systematic Alpha Investments sold 202 Abiomed Inc shares in Q4 2021, an estimated $67K.
  • Systematic Alpha Investments first reported a position in Abiomed Inc in Q3 2021 and held it in 1 quarter.
  • Systematic Alpha Investments's Abiomed Inc position peaked at $67K in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Systematic Alpha Investments's 13F filing for Q4 2021, filed 15 Feb 2022.